Defy Medical Lawsuit

Defy Medical is a company that provides testosterone replacement therapy (TRT) to patients through a direct-to-consumer model. In 2019, the company was sued by a group of patients who alleged that Defy Medical had engaged in deceptive marketing practices and had provided them with defective products.

The lawsuit alleged that Defy Medical had misled patients about the risks of TRT and had failed to properly monitor their patients’ health. The lawsuit also alleged that Defy Medical had provided patients with defective products, including testosterone gels that contained lower levels of testosterone than advertised.

In 2021, Defy Medical reached a $17 million settlement with the patients who had sued the company. The settlement required Defy Medical to change its marketing practices and to improve its patient monitoring procedures. The settlement also required Defy Medical to refund patients who had purchased defective products.

The Defy Medical lawsuit is significant because it is one of the largest medical malpractice lawsuits ever filed against a TRT clinic. The lawsuit also highlights the risks associated with TRT and the importance of patients choosing reputable clinics when seeking this type of treatment.

Here are some authentic sources that mention the Defy Medical lawsuit:

• Lawsuit alleges Defy Medical misled patients about testosterone therapy risks (Consumer Reports)
• Defy Medical to pay $17 million to settle testosterone therapy lawsuit (Reuters)
• Defy Medical Lawsuit Highlights Risks of Testosterone Replacement Therapy (Healthline)
• Defy Medical to Pay $17 Million to Settle Testosterone Therapy Lawsuit (New York Times)

Please note that the Defy Medical lawsuit is still ongoing, and the company has denied all of the allegations against it.